Selected references

  1. Chopra A, Saluja M, Tillu G, et al. A Randomized Controlled Exploratory Evaluation of Standardized Ayurvedic Formulations in Symptomatic Osteoarthritis Knees: A Government of India NMITLI Project. Evid.Based.Complement Alternat.Med 2011;2011:724291.
  2. de Souza, R. F., Lovato da Silva, C. H., Nasser, M., Fedorowicz, Z., and Al-Muharraqi, M. A. Interventions for the management of temporomandibular joint osteoarthritis. Cochrane Database Syst.Rev 2012;4:CD007261.
  3. Dostrovsky NR, Towheed TE, Hudson RW, et al. The effect of glucosamine on glucose metabolism in humans: a systematic review of the literature. Osteoarthritis.Cartilage. 2011;19(4):375-380.
  4. Eggertsen, R., Andreasson, A., and Andren, L. No changes of cholesterol levels with a commercially available glucosamine product in patients treated with lipid lowering drugs: a controlled, randomised, open cross-over trial. BMC.Pharmacol Toxicol. 2012;13(1):10.
  5. Kanzaki, N., Saito, K., Maeda, A., Kitagawa, Y., Kiso, Y., Watanabe, K., Tomonaga, A., Nagaoka, I., and Yamaguchi, H. Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study. J Sci Food Agric. 3-15-2012;92(4):862-869.
  6. Liu, W., Liu, G., Pei, F., Liu, Y., Zhou, Z., Li, J., Shen, B., Kang, P., Xie, Q., and Ma, X. Kashin-Beck disease in Sichuan, China: report of a pilot open therapeutic trial. J Clin Rheumatol. 2012;18(1):8-14.
  7. Murphy, R. K., Ketzler, L., Rice, R. D., Johnson, S. M., Doss, M. S., and Jaccoma, E. H. Oral glucosamine supplements as a possible ocular hypertensive agent. JAMA Ophthalmol. 7-1-2013;131(7):955-957.
  8. Roemer, F. W., Kwoh, C. K., Hannon, M. J., Green, S. M., Jakicic, J. M., Boudreau, R., Crema, M. D., Moore, C. E., and Guermazi, A. Risk factors for magnetic resonance imaging-detected patellofemoral and tibiofemoral cartilage loss during a six-month period: the joints on glucosamine study. Arthritis Rheum. 2012;64(6):1888-1898.
  9. Selvan, T., Rajiah, K., Nainar, M. S., and Mathew, E. M. A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis. ScientificWorldJournal. 2012;2012:902676.
  10. Simon RR, Marks V, Leeds AR, et al. A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals. Diabetes Metab Res Rev. 2011;27(1):14-27.
  11. Smidt D, Torpet LA, Nauntofte B, et al. Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Community Dent.Oral Epidemiol 2011;39(3):276-288.
  12. Trc T and Bohmova J. Efficacy and tolerance of enzymatic hydrolysed collagen (EHC) vs. glucosamine sulphate (GS) in the treatment of knee osteoarthritis (KOA). Int.Orthop. 2011;35(3):341-348.
  13. Van Vijven, J. P., Luijsterburg, P. A., Verhagen, A. P., van Osch, G. J., Kloppenburg, M., and Bierma-Zeinstra, S. M. Symptomatic and chondroprotective treatment with collagen derivatives in osteoarthritis: a systematic review. Osteoarthritis.Cartilage. 2012;20(8):809-821.
  14. Wu, H., Liu, M., Wang, S., Zhao, H., Yao, W., Feng, W., Yan, M., Tang, Y., and Wei, M. Comparative fasting bioavailability and pharmacokinetic properties of 2 formulations of glucosamine hydrochloride in healthy Chinese adult male volunteers. Arzneimittelforschung. 2012;62(8):367-371.
  15. Yue, J., Yang, M., Yi, S., Dong, B., Li, W., Yang, Z., Lu, J., Zhang, R., and Yong, J. Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study. Osteoarthritis.Cartilage. 2012;20(7):622-629.

This evidence-based monograph was prepared by The Natural Standard Research Collaboration

www.naturalstandard.com